To assess whether the SAMM50 gene polymorphisms exhibited association with the severity of NAFLD, we divided the NAFLD patients into two groups (mild fatty liver and moderate to severe fatty liver) (Table 5) according to ultrasonic diagnostic criteria and compared the proportion of moderate to severe fatty liver among the different genotypes. This evidence concerns the gene SAMM50 and metabolic dysfunction-associated steatotic liver disease.